Heritability and rare variant contributions to Alzheimer disease in the Midwestern Amish
Liu, Y.; Song, Y. E.; Wang, W.; Lynn, A.; Miskimen, K.; Fuzzell, S. L.; Hochstetler, S. D.; Laux, R. A.; Miller, D.; Miron, P.; Caywood, L. J.; Clouse, J. E.; Herinton, S. D.; Wang, P.; Gulyayev, A.; Dorfsman, D. A.; Moore, N. C.; Jian, D. Z.; Main, L. R.; Prough, M. B.; Zaman, A. F.; Adams, L. D.; Whitehead, P.; Ogrocki, P.; Lerner, A. J.; Vance, J. M.; Cuccaro, M. L.; Scott, W. K.; Pericak-Vance, M. A.; Haines, J. L.
Show abstract
Background The genetic architecture of Alzheimer disease remains incompletely understood. Founder populations such as the Amish offer a unique opportunity to identify additional genetic variation influencing the disease. Method Using extensive pedigree and genomic data from Midwestern Amish communities, we estimated both pedigree- and SNP- based heritability of AD. In addition, genome-wide association studies and gene-based rare variant tests were performed. Results Heritability estimates suggested that common variants explain much of genetic risk among APOE-{varepsilon}4 carriers, while unexplained heritability remains in non-carriers in the Amish. GWAS confirmed APOE-{varepsilon}4 as the strongest genetic determinant of AD in the Amish. Rare variant analyses identified RIN3 and PILRA as significantly associated with risk of cognitive impairment; suggestive signals including CYP24A1 were also identified. Discussion These findings highlight the contributions of common and rare variants to Alzheimer disease and suggest factors beyond common variants may contribute to disease susceptibility particularly among the APOE-{varepsilon}4 non-carriers.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer’s disease in large cohort 96%
- Pupillary dilation responses as a midlife indicator of risk for Alzheimer’s Disease: Association with Alzheimer’s disease polygenic risk 96%
- Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease 95%
Similar papers in this journal
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 95%
- Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13 94%
- Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer's disease 94%
Similar papers in this journal
- Alzheimer's disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769). 96%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 95%
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 95%
Similar papers in this journal
- Cross-sectional study of plasma phosphorylated Tau 217 in persons without dementia 95%
- Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults 95%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 94%